Moreover, 5% to 10% of BC cases are hereditary, and are due to mutations in specific genes called cancer predisposition genes, which confer varying risks of BC development: high risk (BRCA1 and BRCA2); moderate risk (TP53 and BRIP1); and finally, low risk (ATM and CHEK2) [4]. This evidence concerns the gene BRCA2 and breast cancer.